Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 302
Ph III recruiting: 41
Growth YoY: +2.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 51–100 of 123 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03132922	MAGE-A4ᶜ¹º³²T for Multi-Tumor	active not recruiting	Phase 1	71	USWM CT, LLCINDUSTRY	2	Jun 4, 2026	clinicaltrials
NCT07605663	an AI-Driven Four-Tier Invasion Depth Classification for Early Esophageal Cancer	active not recruiting	—	890	Fudan UniversityOTHER	1	May 26, 2026	clinicaltrials
NCT04494009